Medizinisch geprüft von Kovalenko Svetlana Olegovna, Apotheke Zuletzt aktualisiert am 26.06.2023
Achtung! Die Informationen auf der Seite sind nur für medizinisches Fachpersonal! Die Informationen werden in öffentlichen Quellen gesammelt und können aussagekräftige Fehler enthalten! Seien Sie vorsichtig und überprüfen Sie alle Informationen auf dieser Seite!
Top 20 Medikamente mit den gleichen Inhaltsstoffen:
Usual Adult Dose for Cough:
Immediate release: Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 10 mg-200 mg oral capsule: 2 capsules every 4 hours/ not to exceed 12 capsules/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 5 mg-100 mg oral granule: 2 to 4 packets every 4 hours, not to exceed 6 doses/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 5 mg-100 mg/5 mL oral liquid: 10 mL to 20 mL every 4 hours, not to exceed 120 mL/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 10 mg-100 mg/5 mL oral liquid: 10 mL every 4 hours, not to exceed 60 mL/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 10 mg-200 mg/5 mL oral liquid: 10 mL every 4 hours, not to exceed 60 mL/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 10 mg-200 mg/15 mL oral liquid: 30 mL orally every 4 hours, not to exceed 6 doses in 24 hours
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 15 mg-200 mg/5 mL oral liquid: 10 mL every 6 hours, not to exceed 40 mL/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 20 mg-200 mg/10 mL oral liquid: 10 mL orally every 4 hours, not to exceed 6 doses in 24 hours
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 20 mg-200 mg/30 mL oral liquid: 30 mL orally every 4 hours, not to exceed 6 doses in 24 hours
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 20 mg-400 mg/5 mL oral liquid: 5 mL every 4 hours, not to exceed 6 doses in 24 hours
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 20 mg-400 mg/20 mL oral liquid: 20 mL orally every 4 hours, not to exceed 6 doses in 24 hours
Extended release:
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 30 mg-600 mg oral tablet, extended release: 1 or 2 tablets every 12 hours, not to exceed 4 tablets/day
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 60 mg-1200 mg oral tablet, extended release: 1 tablet every 12 hours. Not to exceed 2 tablets/day
Usual Pediatric Dose for Cough:
12 years and older: Follow adult dosing
Dosing varies by product, please refer to specific labeling:
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 5 mg-100 mg oral granule:
6 to 12 years: 1 to 2 packets every 4 hours, not to exceed 6 doses/day
Under 6 years: Do not use
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 5 mg-100 mg/5 mL oral liquid:
6 to 12 years: 5 mL to 10 mL every 4 hours, not to exceed 60 mL/day
4 to 6 years: 2.5 mL to 5 mL every 4 hours, not to exceed 30 mL/day
Under 4 years: Do not use
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 10 mg-100 mg/5 mL oral liquid:
6 to 12 years: 5 mL every 4 hours, not to exceed 30 mL/day
2 to 6 years: 2.5 mL every 4 hours, not to exceed 15 mL/day
Under 2 years: Do not use
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 10 mg-200 mg/15 mL oral liquid:
6 to 12 years: 15 mL every 4 hours, not to exceed 30 mL/day
4 to 6 years: Ask a doctor
Under 4 years: Do not use
Dextromethorphan (Robafen DM)-Guaifenesin (Robafen DM) 20 mg-200 mg/10 mL oral liquid
6 to 12 years: 5 mL every 4 hours, not to exceed 30 mL/day
2 to 6 years: 2.5 mL every 4 hours, not to exceed 15 mL/day
Under 2 years: Do not use
See also:
What are the possible side effects of Robafen DM?
Paracetamol may cause pancreatitis, allergic reactions in the form of a rash or blood disorders (including neutropenia, pancytopenia, leucopenia, agranulocytosis and thrombocytopenia). These should disappear on stopping the treatment. The rash usually appears as red areas or allergic wheals, and may be accompanied by fever and involvement of the mucous membranes.
The most common side-effect due to chlorpheniramine is sedation varying from slight drowsiness to deep sleep, including lassitude, dizziness, and inco-ordination. Paradoxical central nervous system stimulation may occur especially in children, with insomnia, nervousness, euphoria, irritability, tremors, and less frequently, nightmares, hallucinations, and convulsions.
Other side effects may include dry mouth; thickened respiratory tract secretions and tightness of the chest, blurred vision, urinary difficulty and retention, constipation and increased gastric reflux. In addition, gastro-intestinal disturbances may occur such as nausea, vomiting, diarrhoea or epigastric pain.
Hypersensitivity reactions may occur. Blood disorders including agranulocytosis, leucopenia, haemolytic anaemia and thrombocytopenia, have been reported. Other less frequently reported side-effects include hypotension, tinnitus, headache and paraesthesias.
Chloropheniramine should be given with care to patients with glaucoma, urinary retention, prostatic hypertrophy or pyloroduodenal obstruction. Caution is advised in patients with epilepsy and severe cardiovascular disorders.
Chlorpheniramine may enhance the sedative effect of central nervous system depressants including alcohol, barbiturates, hypnotic, analgesics, sedatives and tranquillisers. Care should be taken when taking medicines containing tricyclic anti-depressants or atropine together.
Elderly patients are more susceptible to the central nervous system depressant and lowering of blood pressure effects even at dose quantities effective for treatment.
The warning signs of damage caused by ototoxic medicines may be masked by chlorpheniramine.
Other central nervous system depressants, such as alcohol, barbiturates, hyponotics, narcotic analgesics, sedatives and tranquillisers, if taken together will increase the chance of sedation. Be careful when taking medicines containing tricyclic anti-depressants or atropine together.
Pseudoephedrine hydrochloride may cause giddiness, headache, nausea, vomiting, sweating, thirst, rapid or irregular heart beat (tachycardia, ventricular arrhythmia), pain in front of the heart (precordial pain), palpitations, raised blood pressure (hypertension), micturition, difficulty in urination, muscular weakness, tremors, anxiety, restlessness and inability to sleep, fear, confusion, psychotic states, reduced appetite, dyspnoea, sweating, hypersalivation, altered metabolism including disturbance in glucose metabolism. Tolerance with dependence may occur after continued use.
The effects of pseudoephedrine hydrochloride are lessened by medicines containing guanethidine, reserpine, methyldopa and may be diminished or enhanced by tricyclic antidepressants. It may increase the possibility of irregular heart beat in patients taking digitalis.
Pseudoephedrine may increase blood pressure and therefore special care is advisable in patients receiving antihypertensive therapy.